Thiopurine S -methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients (original) (raw)
Thiopurine S-Methyltransferase Gene Polymorphisms in a Healthy Slovak Population and Pediatric Patients with Inflammatory Bowel Disease
Alica Chocholova
Nucleosides, Nucleotides and Nucleic Acids, 2013
View PDFchevron_right
Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece
Elias Kouroumalis
European Journal of Gastroenterology & Hepatology, 2017
View PDFchevron_right
Thiopurine S-methyltransferase genetic polymorphisms in adult patients with inflammatory bowel diseases in the Latvian population
Aldis Pukitis
Therapeutic Advances in Gastroenterology
View PDFchevron_right
The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
L. Kadasi, T. Koller
Bratislavské lekárske listy, 2013
View PDFchevron_right
Pharmacogenetics of thiopurine therapy in paediatric IBD patients
Johanna Escher
Alimentary Pharmacology and Therapeutics, 2006
View PDFchevron_right
Association between Thiopurine S-methyltransferase Polymorphisms and Thiopurine-Induced Adverse Drug Reactions in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Son Duong
PloS one, 2015
View PDFchevron_right
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients
Renata Fróes
World journal of gastroenterology : WJG, 2014
View PDFchevron_right
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease
Sven Almer
Gut, 2006
View PDFchevron_right
Allelic variants of the thiopurine s-methyltranferase deficiency in patients with ulcerative colitis and in healthy controls
Cesar Diaz
The American Journal of Gastroenterology, 2000
View PDFchevron_right
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
Rebecca Roberts, Richard Gearry, Murray Barclay
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine
Daniel Carpio
Journal of gastrointestinal and liver diseases : JGLD, 2011
View PDFchevron_right
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease
Taya Kitiyakara
Alimentary Pharmacology & Therapeutics, 2004
View PDFchevron_right
Thiopurine methyltransferase genotype distribution in patients with Crohn's disease
Jens Frederik Dahlerup
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Thiopurine S-methyltransferase activity and single nucleotide polymorphism G 238 C ( TPMT * 2 ) in children with inflammatory bowel disease during azathioprine-induced immunosuppression therapy
Maciej Jankowski
2009
View PDFchevron_right
Prevalence of Methylenetetrahydrofolate Reductase Polymorphisms in Young Patients with Inflammatory Bowel Disease
Tullio Giraldi
Digestive Diseases and Sciences, 2006
View PDFchevron_right
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
Paul Seed
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease
Richard Gearry
Journal of Gastroenterology and Hepatology, 2005
View PDFchevron_right
TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India
Prateek Bhatia
2021
View PDFchevron_right
Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations
Johanna Escher
Digestive and Liver Disease, 2005
View PDFchevron_right
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease
Stefano Martelossi, Alessandro Ventura, Giuliana Decorti
Inflammatory Bowel Diseases, 2007
View PDFchevron_right
Association of genetic polymorphism of NUDT15, TPMT and ITPA gene in the toxicity and efficacy of azathioprine-based regimen in Egyptian inflammatory bowel disease patients
Ahmed A Elberry
Beni-Suef University Journal of Basic and Applied Sciences, 2023
View PDFchevron_right
Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease
Themos Dassopoulos
Clinical Gastroenterology and Hepatology, 2004
View PDFchevron_right
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms
Paolo Lionetti
World journal of gastroenterology : WJG, 2015
View PDFchevron_right
Influences of Thiopurine Methyltransferase Genotype and Activity on Thiopurine-induced Leukopenia in Korean Patients With Inflammatory Bowel Disease
Suk-kyun Yang
Journal of Clinical Gastroenterology, 2010
View PDFchevron_right
Analysis of thiopurine S-methyltransferase phenotype–genotype in a Tunisian population with Crohn’s disease
Sâad Saguem
European Journal of Drug Metabolism and Pharmacokinetics, 2013
View PDFchevron_right
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease
Andre Van Rij
Inflammatory bowel diseases, 2018
View PDFchevron_right
Biomarker-based thiopurine therapy for inflammatory bowel disease
Momir Mikov
Macedonian Pharmaceutical Bulletin
View PDFchevron_right